Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021

Euro Surveill. 2021 Dec;26(48):2101030. doi: 10.2807/1560-7917.ES.2021.26.48.2101030.

Abstract

Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated the risk ratio of case, hospitalisation and death notifications in people 80 years and older compared with 25-59-year-olds. Highest impact was observed for full vaccination uptake 80% or higher with reductions in notification rates of cases up to 65% (IRR: 0.35; 95% CI: 0.13-0.99), hospitalisations up to 78% (IRR: 0.22; 95% CI: 0.13-0.37) and deaths up to 84% (IRR: 0.16; 95% CI: 0.13-0.20).

Keywords: COVID-19; health impact assessment; mass vaccination; vaccination uptake.

MeSH terms

  • Aged
  • COVID-19 Vaccines*
  • COVID-19*
  • Hospitalization
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines